Meet 2024 Award Recipient
Adam Marks
Adam Marks came to the Icahn School of Medicine at Mount Sinai from McGill University, where he majored in biochemistry. Prior to matriculating into the MD-PhD Program in 2018, Adam conducted post-baccalaureate research at Rockefeller University which looked to apply CRISPR-cas9 genome editing tools to human embryonic stem cells to study a variety of diseases with developmental etiologies.
Adam currently works in the lab of Dr. Brian Brown, where he is developing methods for controlling the cell- and organ-specific expression of gene therapies, such as RNA and DNA based drugs, with applications in cancer medicine, vaccinology, and genetic disease. While at Mount Sinai, Adam has also served as a Senior Clinician at the East Harlem Health Outreach Partnership (EHHOP) and works as a teaching assistant extensively between the graduate and medical schools. He is a co-founder of the Sinai Trivia League.
Adam thanks his parents, his dog (Casanova), his mentors, his friends, the MSTP leadership, and his colleagues.
Adam anticipates graduating with an MD-PhD degree in 2026.